Cross-presentation in mouse and human dendritic cells

E Segura, S Amigorena - Advances in immunology, 2015 - Elsevier
Cross-presentation designates the presentation of exogenous antigens on major
histocompatibility complex class I molecules and is essential for the initiation of cytotoxic …

Lipid bodies containing oxidatively truncated lipids block antigen cross-presentation by dendritic cells in cancer

F Veglia, VA Tyurin, D Mohammadyani, M Blasi… - Nature …, 2017 - nature.com
Cross-presentation is a critical function of dendritic cells (DCs) required for induction of
antitumor immune responses and success of cancer immunotherapy. It is established that …

M2 macrophage-derived extracellular vesicles facilitate CD8+ T cell exhaustion in hepatocellular carcinoma via the miR-21-5p/YOD1/YAP/β-catenin pathway

J Pu, Z Xu, J Nian, Q Fang, M Yang, Y Huang, W Li… - Cell death …, 2021 - nature.com
Hepatocellular carcinoma (HCC) is a common malignancy. CD8+ T cell-mediated immune
response is critical for the inhibition of HCC progression. M2 macrophages participate in …

Genetic disruption of mammalian endoplasmic reticulum‐associated protein degradation: Human phenotypes and animal and cellular disease models

S Badawi, FE Mohamed, DS Varghese, BR Ali - Traffic, 2023 - Wiley Online Library
Endoplasmic reticulum‐associated protein degradation (ERAD) is a stringent quality control
mechanism through which misfolded, unassembled and some native proteins are targeted …

[HTML][HTML] Small molecule enhancers of endosome-to-cytosol import augment anti-tumor immunity

P Kozik, M Gros, DN Itzhak, L Joannas… - Cell reports, 2020 - cell.com
Cross-presentation of antigens by dendritic cells (DCs) is critical for initiation of anti-tumor
immune responses. Yet, key steps involved in trafficking of antigens taken up by DCs remain …

Deubiquitinase YOD1 potentiates YAP/TAZ activities through enhancing ITCH stability

Y Kim, W Kim, Y Song, JR Kim, K Cho… - Proceedings of the …, 2017 - National Acad Sciences
Hippo signaling controls the expression of genes regulating cell proliferation and survival
and organ size. The regulation of core components in the Hippo pathway by …

YOD1 serves as a potential prognostic biomarker for pancreatic cancer

Z Zhang, W Zhao, Y Li, Y Li, H Cheng, L Zheng… - Cancer Cell …, 2022 - Springer
Background Ubiquitination is a basic post-translational modification of intracellular proteins
and can be reversed enzymatically by DUBs (deubiquitinating enzymes). More than 90 …

miR-221/222 induce instability of p53 By downregulating deubiquitinase YOD1 in acute myeloid leukemia

HZ Pei, Z Peng, X Zhuang, X Wang, B Lu, Y Guo… - Cell Death …, 2023 - nature.com
Acute myeloid leukemia (AML) is a hematological malignancy characterized by the impaired
differentiation and uncontrolled proliferation of myeloid blasts. Tumor suppressor p53 is …

[HTML][HTML] Blockade of deubiquitinase YOD1 degrades oncogenic PML/RARα and eradicates acute promyelocytic leukemia cells

X Shao, Y Chen, W Wang, W Du, X Zhang… - … Pharmaceutica Sinica B, 2022 - Elsevier
In most acute promyelocytic leukemia (APL) cells, promyelocytic leukemia (PML) fuses to
retinoic acid receptor α (RARα) due to chromosomal translocation, thus generating …

Rab8a restores diverse innate functions in CD11c+CD11b+ dendritic cells from aged mice

S Singh, A Tehseen, S Dahiya, YJ Singh… - Nature …, 2024 - nature.com
Age-related alterations of the immune system compromise the host's ability to respond to
pathogens, but how immune aging is regulated is still poorly understood. Here, we identify …